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The Editorial on the research topic
Essential Pathways and Circuits of Autism Pathogenesis
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments
in social communication skills, as well as stereotyped movements and restricted interests (DSM-5;
American Psychiatric Association, 2013). Appreciation of the genetic etiology of ASD began with
epidemiological studies in the 1970s, revealing the extremely high heritability of the disorder. Since
then over 700 genes have been implicated in the etiology of ASD. A handful of these are highly
potent rare variant mutations (e.g., Mendelian disorders like Fragile X; structural, or copy number
variants, CNVs, like 16p11.2 deletion/duplication; and de novo, rare variant exonic mutations like
chromodomain helicase DNA-binding protein 8, CHD8, gene mutations). Nevertheless, ASD risk
mutations are also incompletely penetrant (only a subset of patients who have the mutation also
have ASD), pleiotropic (all knownmutations are also causes of intellectual disability, schizophrenia,
and/or epilepsy), and likely highly polygenic (i.e., one characteristic is controlled by two or more
genes; estimates for ASD range from 400 to 1000 genes). Accumulating evidence suggests that, in
the face of this etiological complexity, we may be able to understand the emergence of key core
clinical symptoms by examining a limited number of convergent biochemical pathways or brain
circuits. This Frontiers Research Topics brings together a set of review articles, which explore the
existing evidence supporting this view.
Although, deficits in social interactions and restrictive, repetitive patterns of behavioral output
are seemingly unrelated symptom domains, growing appreciation of striatal function suggests that
this brain region regulates behavioral flexibility, motivational state, goal-directed learning, and
attention. The review articles by Fuccillo and Rothwell consider whether alterations in striatal
physiology might be a central node mediating a range of autism-associated behaviors, including
social and cognitive deficits that are hallmarks of the disorder. Similarly, the cerebellum is classically
thought to control fine motor function, but more recent evidence implicates this brain region
in higher cognitive functions as well. Three manuscripts critically review the hypothesis that the
cerebellum is essential for many, if not most of the processes that are perturbed in ASD, including
language and communication, social interactions, stereotyped behavior, motor activity and motor
coordination, and higher cognitive functions (Hampson and Blatt; D’Mello and Stoodley; Mosconi
et al.).
Circuit-level explanations of ASD pathogenesis are appealing because theymost directly account
for the emergence of clinical symptoms; however, because ASD genes are expressed across the
whole brain, it is at this time unclear how specific circuits, cell types and brain regions are more
likely to be involved in producing symptoms. One compelling possibility is that this pattern
emerges through pathoclisis (i.e., the whole brain is exposed to the insult, in this case genetic
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lesion, but certain subtypes of cells, localized to distinct brain
regions or circuits, are more susceptible to injury). Alternatively,
the selective involvement of certain brain regions or circuits
may reflect the case that these circuits are recruited as a
compensatory shunting mechanism for symptoms that arise in
a distributed fashion throughout multiple brain regions and
circuits (this alternative is perhaps analogous to “abdominal
guarding” whereby the muscles of the abdominal wall contract
when there is injury to any of the organs found within the
abdominal cavity). In the case of pathoclisis, future studies
aimed at understanding how certain cell types become selectively
susceptible may yield important pathogenic mechanisms and
therapeutic targets. In the case of compensatory shunting,
examining underlying, and unifying biochemical or molecular
mechanisms will be critical for understanding the pathogenesis.
The first suggestion that ASD might be thought of as a
“synaptopathy” was driven by the observation that the dozen
or so ASD risk genes known at the time, all encode synaptic
proteins, and could be linked together by biochemical signaling
pathways that regulate synaptic pruning and plasticity during
early post-natal development. Later, the Fragile X mental
retardation protein (FMRP), which is absent in patients with
Fragile X (the first identified and most common cause of ASD)
binds to nearly one quarter of identified ASD candidate genes,
suggesting that this protein might serve as a central node for ASD
pathogenesis. Interestingly, even as we discover novel unifying
mechanisms, these early speculations are also being borne out by
genetic pathway analysis. Several reviews in this volume address
these unifying mechanisms revealed by molecular, biochemical,
and genetic pathway analysis.
Baribeau and Anagnostou summarize the known associations
between the oxytocin and vasopressin neuropeptide systems
and social neurocircuits in the brain. Meffert and colleagues
review evidence that genetically diverse forms of ASD may be
usefully parsed into entities resulting from converse patterns
of growth regulation at the molecular level, which lead to
the correlates of general synaptic and neural overgrowth or
undergrowth (Subramanian et al.). Sell and Margolis examine
the hypothesis that changes in UBE3A protein levels alter the
levels of a collection of protein substrates giving rise to the
unique phenotypic aspects of UBE3A associated ASDs. Huang
andHsueh focus T-brain-1 (TBR1) and argue that this gene serves
as a node for ASD pathogenesis, as well as reviews their recent
evidence that Tbr1+/− ASD model mice show amygdalar wiring
and NMDAR hypoactivity phenotypes. O’Roak and colleagues
focus on genes involved in transcriptional regulation, such as
chromatin modifiers and summarizes evidence that CHD8, a
chromatin remodeling factor, may serve as a “master regulator”
of a common ASD etiology (Barnard et al.). Dougherty and
colleagues consider evidence from genetic pathway analysis that
reveal clusters of ASD associated genes, which are involved in a
handful of cellular functions, as well as the developmental time
course, brain region and cell-type specificity of those functions
(Kopp et al.).
We are currently at a critical juncture in ASD research. As we
discover more and more pathogenic mechanisms, it is important
to step back and synthesize so that we may generate novel
testable hypothesis about whether and how these mechanisms
may intersect to produce the common symptoms of ASD. We
hope that the papers brought together in this Frontiers Research
Topic will serve to stimulate that conversation and provide the
readers with new ideas and perspectives toward such convergent
mechanisms and circuits.
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